+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Chronic Pain Treatment Market Research Report: By Product, Indication, Application, Distribution Channel, End User - Global Industry Analysis and Growth Forecast to 2030

  • ID: 5201160
  • Report
  • September 2020
  • Region: Global
  • 403 Pages
  • Prescient & Strategic Intelligence Private Limited

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc
The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate a revenue of $151.7 billion in 2030. The factors fueling the expansion of the market are the rising implementation of favorable policies by various governments, soaring geriatric population and the subsequent rise in the need for elderly care, and the growing incidence of chronic diseases across the world.

The drugs category is further divided into NSAIDs (non-steroidal anti-inflammatory drugs), opioids, antidepressants, and anticonvulsants. Out of these, the opioids are predicted to register the highest growth in the chronic pain treatment market in the upcoming years, on account of the extensive utilization of these drugs for relieving pain, reducing sprains and strains and inflammation, and reducing the body temperature.

On the other hand, the devices category is classified into ablation devices, analgesic infusion pumps, and neurostimulation devices. Amongst these, the neurostimulation devices category registered the highest growth in the market in the years gone by. This was due to the high public awareness about these devices in various countries and the high popularity of these devices among both patients and doctors around the world.

Globally, the chronic pain treatment market recorded the highest growth in North America during the past few years and this trend would continue in the forthcoming years as well. This would be a result of the growing geriatric population, the existence of several chronic pain management medicines and devices and the rising prevalence of chronic diseases in the region.

The players operating in the chronic pain treatment market are increasingly focusing on product launches for gaining foothold in the market. For example, the FDA approved Voltaren Arthritis Pain, which has been recently developed by GlaxoSmithKline plc, in February 2020. This product provides temporary relief to the patient from arthritis pain and is suitable for people in the age group 18 years and above. The FDA approval made this product the first prescription-strength NSAID topical gel for arthritis pain available OTC in the U.S.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca plc
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc

Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Product
1.3.2 Market Segmentation by Indication
1.3.3 Market Segmentation by Application
1.3.4 Market Segmentation by Distribution Channel
1.3.5 Market Segmentation by End User
1.3.6 Market Segmentation by Region
1.3.7 Analysis Period
1.3.8 Market Data Reporting Unit
1.3.8.1 Value
1.4 Key Stakeholders


Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study


Chapter 3. Executive Summary


Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Product
4.1.1.1 Drugs
4.1.1.1.1 Opioids
4.1.1.1.2 NSAIDs
4.1.1.1.3 Anticonvulsants
4.1.1.1.4 Antidepressants
4.1.1.1.5 Others
4.1.2 By Devices
4.1.2.1 Neurostimulation devices
4.1.2.1.1 SCS
4.1.2.1.2 TENS
4.1.2.1.3 Others
4.1.2.2 Analgesic infusion pumps
4.1.2.3 Ablation devices
4.1.2.3.1 Radiofrequency ablation devices
4.1.2.3.2 Cryoablation devices
4.1.3 By Indication
4.1.3.1 Neuropathic pain
4.1.3.2 Arthritis pain
4.1.3.3 Chronic back pain
4.1.3.4 Cancer pain
4.1.3.5 Migraine
4.1.3.6 Fibromyalgia
4.1.3.7 Others
4.1.4 By Application
4.1.4.1 Musculoskeletal
4.1.4.2 Neuropathy
4.1.4.3 Oncology
4.1.4.4 Others
4.1.5 By Distribution channel
4.1.5.1 Direct
4.1.5.2 Indirect
4.1.6 By End User
4.1.6.1 Hospitals
4.1.6.2 Clinics
4.1.6.3 Nursing homes
4.1.6.4 Research centers & universities
4.1.6.5 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Innovations in the field of pain management
4.2.1.2 Increasing number of product approvals
4.2.2 Drivers
4.2.2.1 Increasing government support for chronic pain management
4.2.2.2 Growing geriatric population
4.2.2.3 Surging prevalence of chronic health conditions
4.2.2.4 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Side effects associated with pain management drugs and devices
4.2.3.2 Product recalls
4.2.3.3 Patent expiry of blockbuster chronic pain treatment drugs
4.2.3.4 Increasing usage of opioids and antidepressants
4.2.3.5 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Untapped markets in developing economies
4.3 Porter’s Five Forces Analysis
4.4 Impact of COVID-19


Chapter 5. Industry Insights
5.1 Epidemiological Analysis of Chronic Pain Indications
5.1.1 North America
5.1.2 Europe
5.1.3 Japan
5.1.4 China
5.2 Pricing and Reimbursement Scenario
5.2.1 Pricing
5.2.2 Reimbursement Scenario
5.2.2.1 U.S.
5.2.2.2 Europe
5.2.2.3 Japan
5.3 Research Funding and Government Initiatives
5.4 Pipeline Drugs for Chronic Pain
5.5 Key Products Expected to be Launched
5.6 Treatment


Chapter 6. Global Market Size and Forecast
6.1 By Product
6.1.1 Chronic Pain Drugs Market, by Type
6.1.2 Chronic Pain Devices Market, by Type
6.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
6.1.2.2 Ablation devices market for chronic pain treatment, by type
6.2 By Indication
6.3 By Application
6.4 By Distribution Channel
6.5 By End User
6.6 By Region


Chapter 7. North America Market Size and Forecast
7.1 By Product
7.1.1 Chronic Pain Drugs Market, by Type
7.1.2 Chronic Pain Devices Market, by Type
7.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
7.1.2.2 Ablation devices market for chronic pain treatment, by type
7.2 By Indication
7.3 By Application
7.4 By Distribution Channel
7.5 By End User
7.6 By Country
7.6.1 U.S. Market Size and Forecast
7.6.1.1 By product
7.6.1.1.1 Chronic pain drugs market, by type
7.6.1.1.2 Chronic pain devices market, by type
7.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
7.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type
7.6.1.2 By indication
7.6.1.3 By application
7.6.1.4 By distribution channel
7.6.1.5 By end user
7.6.2 Canada Market Size and Forecast
7.6.2.1 By product
7.6.2.1.1 Chronic pain drugs market, by type
7.6.2.1.2 Chronic pain devices market, by type
7.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
7.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type
7.6.2.2 By indication
7.6.2.3 By application
7.6.2.4 By distribution channel
7.6.2.5 By end user


Chapter 8. Europe Market Size and Forecast
8.1 By Product
8.1.1 Chronic Pain Drugs Market, by Type
8.1.2 Chronic Pain Devices Market, by Type
8.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.1.2.2 Ablation devices market for chronic pain treatment, by type
8.2 By Indication
8.3 By Application
8.4 By Distribution Channel
8.5 By End User
8.6 By Country
8.6.1 Germany Market Size and Forecast
8.6.1.1 By product
8.6.1.1.1 Chronic pain drugs market, by type
8.6.1.1.2 Chronic pain devices market, by type
8.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.1.2 By indication
8.6.1.3 By application
8.6.1.4 By distribution channel
8.6.1.5 By end user
8.6.2 France Market Size and Forecast
8.6.2.1 By product
8.6.2.1.1 Chronic pain drugs market, by type
8.6.2.1.2 Chronic pain devices market, by type
8.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.2.2 By indication
8.6.2.3 By application
8.6.2.4 By distribution channel
8.6.2.5 By end user
8.6.3 U.K. Market Size and Forecast
8.6.3.1 By product
8.6.3.1.1 Chronic pain drugs market, by type
8.6.3.1.2 Chronic pain devices market, by type
8.6.3.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.3.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.3.2 By indication
8.6.3.3 By application
8.6.3.4 By distribution channel
8.6.3.5 By end user
8.6.4 Italy Market Size and Forecast
8.6.4.1 By product
8.6.4.1.1 Chronic pain drugs market, by type
8.6.4.1.2 Chronic pain devices market, by type
8.6.4.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.4.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.4.2 By indication
8.6.4.3 By application
8.6.4.4 By distribution channel
8.6.4.5 By end user
8.6.5 Spain Market Size and Forecast
8.6.5.1 By product
8.6.5.1.1 Chronic pain drugs market, by type
8.6.5.1.2 Chronic pain devices market, by type
8.6.5.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.5.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.5.2 By indication
8.6.5.3 By application
8.6.5.4 By distribution channel
8.6.5.5 By end user
8.6.6 Netherlands Market Size and Forecast
8.6.6.1 By product
8.6.6.1.1 Chronic pain drugs market, by type
8.6.6.1.2 Chronic pain devices market, by type
8.6.6.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.6.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.6.2 By indication
8.6.6.3 By application
8.6.6.4 By distribution channel
8.6.6.5 By end user
8.6.7 Russia Market Size and Forecast
8.6.7.1 By product
8.6.7.1.1 Chronic pain drugs market, by type
8.6.7.1.2 Chronic pain devices market, by type
8.6.7.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.7.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.7.2 By indication
8.6.7.3 By application
8.6.7.4 By distribution channel
8.6.7.5 By end user
8.6.8 Sweden Market Size and Forecast
8.6.8.1 By product
8.6.8.1.1 Chronic pain drugs market, by type
8.6.8.1.2 Chronic pain devices market, by type
8.6.8.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.8.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.8.2 By indication
8.6.8.3 By application
8.6.8.4 By distribution channel
8.6.8.5 By end user
8.6.9 Switzerland Market Size and Forecast
8.6.9.1 By product
8.6.9.1.1 Chronic pain drugs market, by type
8.6.9.1.2 Chronic pain devices market, by type
8.6.9.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
8.6.9.1.2.2 Ablation devices market for chronic pain treatment, by type
8.6.9.2 By indication
8.6.9.3 By application
8.6.9.4 By distribution channel
8.6.9.5 By end user


Chapter 9. APAC Market Size and Forecast
9.1 By Product
9.1.1 Chronic Pain Drugs Market, by Type
9.1.2 Chronic Pain Devices Market, by Type
9.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.1.2.2 Ablation devices market for chronic pain treatment, by type
9.2 By Indication
9.3 By Application
9.4 By Distribution Channel
9.5 By End User
9.6 By Country
9.6.1 Japan Market Size and Forecast
9.6.1.1 By product
9.6.1.1.1 Chronic pain drugs market, by type
9.6.1.1.2 Chronic pain devices market, by type
9.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type
9.6.1.2 By indication
9.6.1.3 By application
9.6.1.4 By distribution channel
9.6.1.5 By end user
9.6.2 China Market Size and Forecast
9.6.2.1 By product
9.6.2.1.1 Chronic pain drugs market, by type
9.6.2.1.2 Chronic pain devices market, by type
9.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type
9.6.2.2 By indication
9.6.2.3 By application
9.6.2.4 By distribution channel
9.6.2.5 By end user
9.6.3 India Market Size and Forecast
9.6.3.1 By product
9.6.3.1.1 Chronic pain drugs market, by type
9.6.3.1.2 Chronic pain devices market, by type
9.6.3.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.6.3.1.2.2 Ablation devices market for chronic pain treatment, by type
9.6.3.2 By indication
9.6.3.3 By application
9.6.3.4 By distribution channel
9.6.3.5 By end user
9.6.4 Australia Market Size and Forecast
9.6.4.1 By product
9.6.4.1.1 Chronic pain drugs market, by type
9.6.4.1.2 Chronic pain devices market, by type
9.6.4.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.6.4.1.2.2 Ablation devices market for chronic pain treatment, by type
9.6.4.2 By indication
9.6.4.3 By application
9.6.4.4 By distribution channel
9.6.4.5 By end user
9.6.5 South Korea Market Size and Forecast
9.6.5.1 By product
9.6.5.1.1 Chronic pain drugs market, by type
9.6.5.1.2 Chronic pain devices market, by type
9.6.5.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
9.6.5.1.2.2 Ablation devices market for chronic pain treatment, by type
9.6.5.2 By indication
9.6.5.3 By application
9.6.5.4 By distribution channel
9.6.5.5 By end user


Chapter 10. LATAM Market Size and Forecast
10.1 By Product
10.1.1 Chronic Pain Drugs Market, by Type
10.1.2 Chronic Pain Devices Market, by Type
10.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
10.1.2.2 Ablation devices market for chronic pain treatment, by type
10.2 By Indication
10.3 By Application
10.4 By Distribution Channel
10.5 By End User
10.6 By Country
10.6.1 Brazil Market Size and Forecast
10.6.1.1 By product
10.6.1.1.1 Chronic pain drugs market, by type
10.6.1.1.2 Chronic pain devices market, by type
10.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
10.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type
10.6.1.2 By indication
10.6.1.3 By application
10.6.1.4 By distribution channel
10.6.1.5 By end user
10.6.2 Mexico Market Size and Forecast
10.6.2.1 By product
10.6.2.1.1 Chronic pain drugs market, by type
10.6.2.1.2 Chronic pain devices market, by type
10.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
10.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type
10.6.2.2 By indication
10.6.2.3 By application
10.6.2.4 By distribution channel
10.6.2.5 By end user


Chapter 11. MEA Market Size and Forecast
11.1 By Product
11.1.1 Chronic Pain Drugs Market, by Type
11.1.2 Chronic Pain Devices Market, by Type
11.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
11.1.2.2 Ablation devices market for chronic pain treatment, by type
11.2 By Indication
11.3 By Application
11.4 By Distribution Channel
11.5 By End User
11.6 By Country
11.6.1 Saudi Arabia Market Size and Forecast
11.6.1.1 By product
11.6.1.1.1 Chronic pain drugs market, by type
11.6.1.1.2 Chronic pain devices market, by type
11.6.1.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
11.6.1.1.2.2 Ablation devices market for chronic pain treatment, by type
11.6.1.2 By indication
11.6.1.3 By application
11.6.1.4 By distribution channel
11.6.1.5 By end user
11.6.2 South Africa Market Size and Forecast
11.6.2.1 By product
11.6.2.1.1 Chronic pain drugs market, by type
11.6.2.1.2 Chronic pain devices market, by type
11.6.2.1.2.1 Neurostimulation devices market for chronic pain treatment, by type
11.6.2.1.2.2 Ablation devices market for chronic pain treatment, by type
11.6.2.2 By indication
11.6.2.3 By application
11.6.2.4 By distribution channel
11.6.2.5 By end user


Chapter 12. Competitive Landscape
12.1 Product Benchmarking of Key Players
12.2 Global Strategic Developments of Key Players
12.2.1 Product Launches and Approvals
12.2.2 Mergers and Acquisitions
12.2.3 Partnerships, Collaborations, and Agreements


Chapter 13. Company Profiles
13.1 Eli Lilly and Company
13.1.1 Business Overview
13.1.2 Product and Service Offerings
13.1.2.1 Marketed products
13.1.2.2 Pipeline products
13.1.3 Key Financial Summary
13.2 GlaxoSmithKline plc
13.2.1 Business Overview
13.2.2 Product and Service Offerings
13.2.2.1 Marketed products
13.2.2.2 Pipeline products
13.2.3 Key Financial Summary
13.3 Pfizer Inc.
13.3.1 Business Overview
13.3.2 Product and Service Offerings
13.3.2.1 Marketed products
13.3.2.2 Pipeline products
13.3.3 Key Financial Summary
13.4 Medtronic plc
13.4.1 Business Overview
13.4.2 Product and Service Offerings
13.4.3 Key Financial Summary
13.5 Abbott Laboratories
13.5.1 Business Overview
13.5.2 Product and Service Offerings
13.5.3 Key Financial Summary
13.6 Boston Scientific Corporation
13.6.1 Business Overview
13.6.2 Product and Service Offerings
13.6.3 Key Financial Summary
13.7 Novartis AG
13.7.1 Business Overview
13.7.2 Product and Service Offerings
13.7.2.1 Marketed products
13.7.2.2 Pipeline products
13.7.3 Key Financial Summary
13.8 Johnson & Johnson
13.8.1 Business Overview
13.8.2 Product and Service Offerings
13.8.2.1 Marketed products
13.8.2.2 Pipeline products
13.8.3 Key Financial Summary
13.9 AstraZeneca plc
13.9.1 Business Overview
13.9.2 Product and Service Offerings
13.9.2.1 Marketed products
13.9.2.2 Pipeline products
13.9.3 Key Financial Summary
13.10 Bristol-Myers Squibb Company
13.10.1 Business Overview
13.10.2 Product and Service Offerings
13.10.2.1 Marketed products
13.10.2.2 Pipeline products
13.10.3 Key Financial Summary
13.11 Becton, Dickinson and Company
13.11.1 Business Overview
13.11.2 Product and Service Offerings
13.11.3 Key Financial Summary
13.12 Sanofi S.A.
13.12.1 Business Overview
13.12.2 Product and Service Offerings
13.12.2.1 Marketed products
13.12.2.2 Pipeline products
13.12.3 Key Financial Summary


Chapter 14. Appendix
14.1 Abbreviations
14.2 Sources and References
14.3 Related Reports


LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 PATENT EXPIRATION OF SOME CHRONIC PAIN TREATMENT DRUGS
TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 5 PRICE LISTING OF SOME MARKETED DRUGS FOR CHRONIC PAIN TREATMENT
TABLE 6 PRICE LISTING OF SOME MARKETED DEVICES FOR CHRONIC PAIN TREATMENT
TABLE 7 LIST OF DRUGS UNDER REGULATORY REVIEW, PRE-REGISTRATION, AND FILED STAGES
TABLE 8 LIST OF DRUGS IN PHASE III STAGE OF DEVELOPMENT
TABLE 9 LIST OF DRUGS IN PHASE II STAGE OF DEVELOPMENT
TABLE 10 LIST OF DRUGS IN PHASE I STAGE OF DEVELOPMENT
TABLE 11 LIST OF DRUGS IN PRE-CLINICAL STAGE OF DEVELOPMENT
TABLE 12 LIST OF DISCOVERY DRUGS
TABLE 13 LIST OF DRUGS FOR WHICH NEW DRUG APPLICATION (NDA) HAS BEEN FILED
TABLE 14 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 15 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 16 GLOBAL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 17 GLOBAL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 18 GLOBAL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 19 GLOBAL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 20 GLOBAL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 21 GLOBAL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 22 GLOBAL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 23 GLOBAL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 24 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 25 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 26 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 27 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 28 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 29 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 30 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 31 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 32 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY REGION, $M (2014–2019)
TABLE 33 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY REGION, $M (2020–2030)
TABLE 34 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 35 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 36 NORTH AMERICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 37 NORTH AMERICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 38 NORTH AMERICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 39 NORTH AMERICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 40 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 41 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 42 NORTH AMERICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 43 NORTH AMERICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 44 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 45 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 46 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 47 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 48 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 49 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 50 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 51 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 52 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2019)
TABLE 53 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2020–2030)
TABLE 54 U.S. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 55 U.S. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 56 U.S. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 57 U.S. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 58 U.S. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 59 U.S. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 60 U.S. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 61 U.S. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 62 U.S. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 63 U.S. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 64 U.S. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 65 U.S. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 66 U.S. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 67 U.S. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 68 U.S. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 69 U.S. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 70 U.S. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 71 U.S. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 72 CANADA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 73 CANADA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 74 CANADA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 75 CANADA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 76 CANADA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 77 CANADA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 78 CANADA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 79 CANADA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 80 CANADA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 81 CANADA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 82 CANADA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 83 CANADA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 84 CANADA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 85 CANADA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 86 CANADA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 87 CANADA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 88 CANADA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 89 CANADA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 90 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 91 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 92 EUROPE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 93 EUROPE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 94 EUROPE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 95 EUROPE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 96 EUROPE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 97 EUROPE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 98 EUROPE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 99 EUROPE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 100 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 101 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 102 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 103 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 104 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 105 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 106 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 107 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 108 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2019)
TABLE 109 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2020–2030)
TABLE 110 GERMANY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 111 GERMANY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 112 GERMANY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 113 GERMANY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 114 GERMANY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 115 GERMANY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 116 GERMANY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 117 GERMANY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 118 GERMANY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 119 GERMANY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 120 GERMANY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 121 GERMANY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 122 GERMANY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 123 GERMANY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 124 GERMANY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 125 GERMANY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 126 GERMANY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 127 GERMANY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 128 FRANCE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 129 FRANCE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 130 FRANCE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 131 FRANCE CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 132 FRANCE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 133 FRANCE CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 134 FRANCE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 135 FRANCE NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 136 FRANCE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 137 FRANCE ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 138 FRANCE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 139 FRANCE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 140 FRANCE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 141 FRANCE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 142 FRANCE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 143 FRANCE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 144 FRANCE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 145 FRANCE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 146 U.K. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 147 U.K. CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 148 U.K. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 149 U.K. CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 150 U.K. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 151 U.K. CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 152 U.K. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 153 U.K. NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 154 U.K. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 155 U.K. ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 156 U.K. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 157 U.K. CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 158 U.K. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 159 U.K. CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 160 U.K. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 161 U.K. CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 162 U.K. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 163 U.K. CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 164 ITALY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 165 ITALY CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 166 ITALY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 167 ITALY CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 168 ITALY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 169 ITALY CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 170 ITALY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 171 ITALY NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 172 ITALY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 173 ITALY ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 174 ITALY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 175 ITALY CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 176 ITALY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 177 ITALY CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 178 ITALY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 179 ITALY CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 180 ITALY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 181 ITALY CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 182 SPAIN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 183 SPAIN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 184 SPAIN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 185 SPAIN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 186 SPAIN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 187 SPAIN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 188 SPAIN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 189 SPAIN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 190 SPAIN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 191 SPAIN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 192 SPAIN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 193 SPAIN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 194 SPAIN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 195 SPAIN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 196 SPAIN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 197 SPAIN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 198 SPAIN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 199 SPAIN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 200 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 201 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 202 NETHERLANDS CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 203 NETHERLANDS CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 204 NETHERLANDS CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 205 NETHERLANDS CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 206 NETHERLANDS NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 207 NETHERLANDS NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 208 NETHERLANDS ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 209 NETHERLANDS ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 210 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 211 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 212 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 213 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 214 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 215 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 216 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 217 NETHERLANDS CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 218 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 219 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 220 RUSSIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 221 RUSSIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 222 RUSSIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 223 RUSSIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 224 RUSSIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 225 RUSSIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 226 RUSSIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 227 RUSSIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 228 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 229 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 230 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 231 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 232 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 233 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 234 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 235 RUSSIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 236 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 237 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 238 SWEDEN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 239 SWEDEN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 240 SWEDEN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 241 SWEDEN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 242 SWEDEN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 243 SWEDEN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 244 SWEDEN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 245 SWEDEN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 246 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 247 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 248 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 249 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 250 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 251 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 252 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 253 SWEDEN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 254 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 255 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 256 SWITZERLAND CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 257 SWITZERLAND CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 258 SWITZERLAND CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 259 SWITZERLAND CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 260 SWITZERLAND NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 261 SWITZERLAND NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 262 SWITZERLAND ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 263 SWITZERLAND ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 264 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 265 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 266 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 267 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 268 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 269 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 270 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 271 SWITZERLAND CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 272 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 273 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 274 APAC CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 275 APAC CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 276 APAC CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 277 APAC CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 278 APAC NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 279 APAC NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 280 APAC ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 281 APAC ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 282 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 283 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 284 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 285 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 286 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 287 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 288 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 289 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 290 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2019)
TABLE 291 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2020–2030)
TABLE 292 JAPAN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 293 JAPAN CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 294 JAPAN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 295 JAPAN CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 296 JAPAN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 297 JAPAN CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 298 JAPAN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 299 JAPAN NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 300 JAPAN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 301 JAPAN ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 302 JAPAN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 303 JAPAN CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 304 JAPAN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 305 JAPAN CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 306 JAPAN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 307 JAPAN CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 308 JAPAN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 309 JAPAN CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 310 CHINA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 311 CHINA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 312 CHINA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 313 CHINA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 314 CHINA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 315 CHINA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 316 CHINA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 317 CHINA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 318 CHINA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 319 CHINA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 320 CHINA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 321 CHINA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 322 CHINA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 323 CHINA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 324 CHINA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 325 CHINA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 326 CHINA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 327 CHINA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 328 INDIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 329 INDIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 330 INDIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 331 INDIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 332 INDIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 333 INDIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 334 INDIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 335 INDIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 336 INDIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 337 INDIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 338 INDIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 339 INDIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 340 INDIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 341 INDIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 342 INDIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 343 INDIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 344 INDIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 345 INDIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 346 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 347 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 348 AUSTRALIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 349 AUSTRALIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 350 AUSTRALIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 351 AUSTRALIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 352 AUSTRALIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 353 AUSTRALIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 354 AUSTRALIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 355 AUSTRALIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 356 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 357 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 358 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 359 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 360 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 361 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 362 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 363 AUSTRALIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 364 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 365 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 366 SOUTH KOREA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 367 SOUTH KOREA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 368 SOUTH KOREA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 369 SOUTH KOREA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 370 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 371 SOUTH KOREA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 372 SOUTH KOREA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 373 SOUTH KOREA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 374 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 375 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 376 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 377 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 378 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 379 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 380 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 381 SOUTH KOREA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 382 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 383 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 384 LATAM CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 385 LATAM CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 386 LATAM CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 387 LATAM CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 388 LATAM NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 389 LATAM NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 390 LATAM ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 391 LATAM ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 392 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 393 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 394 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 395 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 396 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 397 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 398 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 399 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 400 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2019)
TABLE 401 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2020–2030)
TABLE 402 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 403 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 404 BRAZIL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 405 BRAZIL CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 406 BRAZIL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 407 BRAZIL CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 408 BRAZIL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 409 BRAZIL NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 410 BRAZIL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 411 BRAZIL ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 412 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 413 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 414 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 415 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 416 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 417 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 418 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 419 BRAZIL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 420 MEXICO CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 421 MEXICO CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 422 MEXICO CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 423 MEXICO CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 424 MEXICO CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 425 MEXICO CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 426 MEXICO NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 427 MEXICO NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 428 MEXICO ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 429 MEXICO ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 430 MEXICO CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 431 MEXICO CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 432 MEXICO CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 433 MEXICO CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 434 MEXICO CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 435 MEXICO CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 436 MEXICO CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 437 MEXICO CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 438 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 439 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 440 MEA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 441 MEA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 442 MEA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 443 MEA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 444 MEA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 445 MEA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 446 MEA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 447 MEA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 448 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 449 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 450 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 451 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 452 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 453 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 454 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 455 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 456 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2019)
TABLE 457 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2020–2030)
TABLE 458 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 459 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 460 SAUDI ARABIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 461 SAUDI ARABIA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 462 SAUDI ARABIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 463 SAUDI ARABIA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 464 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 465 SAUDI ARABIA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 466 SAUDI ARABIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 467 SAUDI ARABIA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 468 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 469 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 470 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 471 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 472 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 473 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 474 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 475 SAUDI ARABIA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 476 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2019)
TABLE 477 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2020–2030)
TABLE 478 SOUTH AFRICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2014–2019)
TABLE 479 SOUTH AFRICA CHRONIC PAIN DRUGS MARKET, BY TYPE, $M (2020–2030)
TABLE 480 SOUTH AFRICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2014–2019)
TABLE 481 SOUTH AFRICA CHRONIC PAIN DEVICES MARKET, BY TYPE, $M (2020–2030)
TABLE 482 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 483 SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 484 SOUTH AFRICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2014–2019)
TABLE 485 SOUTH AFRICA ABLATION DEVICES MARKET FOR CHRONIC PAIN TREATMENT, BY TYPE, $M (2020–2030)
TABLE 486 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2019)
TABLE 487 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2020–2030)
TABLE 488 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2019)
TABLE 489 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2020–2030)
TABLE 490 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2019)
TABLE 491 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2020–2030)
TABLE 492 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2019)
TABLE 493 SOUTH AFRICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2020–2030)
TABLE 494 ELI LILLY AND COMPANY – AT A GLANCE
TABLE 495 ELI LILLY AND COMPANY – KEY FINANCIAL SUMMARY
TABLE 496 GLAXOSMITHKLINE PLC – AT A GLANCE
TABLE 497 GLAXOSMITHKLINE PLC – KEY FINANCIAL SUMMARY
TABLE 498 PFIZER INC. – AT A GLANCE
TABLE 499 PFIZER INC. – KEY FINANCIAL SUMMARY
TABLE 500 MEDTRONIC PLC – AT A GLANCE
TABLE 501 MEDTRONIC PLC – KEY FINANCIAL SUMMARY
TABLE 502 ABBOTT LABORATORIES – AT A GLANCE
TABLE 503 ABBOTT LABORATORIES – KEY FINANCIAL SUMMARY
TABLE 504 BOSTON SCIENTIFIC CORPORATION – AT A GLANCE
TABLE 505 BOSTON SCIENTIFIC COPORATION – KEY FINANCIAL SUMMARY
TABLE 506 NOVARTIS AG – AT A GLANCE
TABLE 507 NOVARTIS AG – KEY FINANCIAL SUMMARY
TABLE 508 JOHNSON & JOHNSON – AT A GLANCE
TABLE 509 JOHNSON & JOHNSON – KEY FINANCIAL SUMMARY
TABLE 510 ASTRAZENECA PLC – AT A GLANCE
TABLE 511 ASTRAZENECA PLC – KEY FINANCIAL SUMMARY
TABLE 512 BRISTOL-MYERS SQUIBB COMPANY – AT A GLANCE
TABLE 513 BRISTOL-MYERS SQUIBB COMPANY – KEY FINANCIAL SUMMARY
TABLE 514 BECTON, DICKINSON AND COMPANY – AT A GLANCE
TABLE 515 BECTON, DICKINSON AND COMPANY – KEY FINANCIAL SUMMARY
TABLE 516 SANOFI S.A. – AT A GLANCE
TABLE 517 SANOFI S.A. – KEY FINANCIAL SUMMARY


LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL CHRONIC PAIN TREATMENT MARKET SUMMARY
FIG 9 BARGAINING POWER OF BUYERS
FIG 10 BARGAINING POWER OF SUPPLIERS
FIG 11 INTENSITY OF RIVALRY
FIG 12 THREAT OF NEW ENTRANTS
FIG 13 THREAT OF SUBSTITUTES
FIG 14 TREATMENT PROCEDURES FOR CHRONIC PAIN
FIG 15 SNAPSHOT OF GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, 2019
FIG 16 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 17 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 18 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 19 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 20 GLOBAL CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 21 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET SNAPSHOT
FIG 22 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 23 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 24 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 25 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 26 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 27 NORTH AMERICA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2030)
FIG 28 EUROPE CHRONIC PAIN TREATMENT MARKET SNAPSHOT
FIG 29 EUROPE CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 30 EUROPE CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 31 EUROPE CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 32 EUROPE CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 33 EUROPE CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 34 EUROPE CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2030)
FIG 35 APAC CHRONIC PAIN TREATMENT MARKET SNAPSHOT
FIG 36 APAC CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 37 APAC CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 38 APAC CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 39 APAC CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 40 APAC CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 41 APAC CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2030)
FIG 42 LATAM CHRONIC PAIN TREATMENT MARKET SNAPSHOT
FIG 43 LATAM CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 44 LATAM CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 45 LATAM CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 46 LATAM CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 47 LATAM CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 48 LATAM CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–2030)
FIG 49 MEA CHRONIC PAIN TREATMENT MARKET SNAPSHOT
FIG 50 MEA CHRONIC PAIN TREATMENT MARKET, BY PRODUCT, $M (2014–2030)
FIG 51 MEA CHRONIC PAIN TREATMENT MARKET, BY INDICATION, $M (2014–2030)
FIG 52 MEA CHRONIC PAIN TREATMENT MARKET, BY APPLICATION, $M (2014–2030)
FIG 53 MEA CHRONIC PAIN TREATMENT MARKET, BY DISTRIBUTION CHANNEL, $M (2014–2030)
FIG 54 MEA CHRONIC PAIN TREATMENT MARKET, BY END USER, $M (2014–2030)
FIG 55 MEA CHRONIC PAIN TREATMENT MARKET, BY COUNTRY, $M (2014–200)
FIG 56 PRODUCT BENCHMARKING OF KEY PLAYERS IN CHRONIC PAIN TREATMENT DRUGS MARKET
FIG 57 PRODUCT BENCHMARKING OF KEY PLAYERS IN CHRONIC PAIN TREATMENT DEVICES MARKET
FIG 58 ELI LILLY AND COMPANY – REVENUE SPLIT BY PRODUCT CATEGORY AND GEOGRAPHY (2019)
FIG 59 GLAXOSMITHKLINE PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 60 PFIZER INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 61 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 62 ABBOTT LABORATORIES – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 63 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 64 NOVARTIS AG – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 65 JOHNSON & JOHNSON – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 66 ASTRAZENECA PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 67 BRISTOL-MYERS SQUIBB COMPANY – REVENUE SPLIT BY BRAND AND GEOGRAPHY (2019)
FIG 68 BECTON, DICKINSON AND COMPANY – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
FIG 69 SANOFI S.A. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)


Note: Product cover images may vary from those shown
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Novartis AG
  • Johnson & Johnson
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Becton, Dickinson and Company
  • Sanofi S.A.
Note: Product cover images may vary from those shown

Loading
LOADING...